Improved Neurodevelopmental Outcomes following Long-Term High-Dose Oral Acyclovir Therapy in Infants with Central Nervous System and Disseminated Herpes Simplex Disease
Authors:
- D K BenjaminDBD K Benjamin
- P PalasanthiranPPP Palasanthiran
- K O'DonnellKOK O'Donnell
- L T GutmanLGL T Gutman
- 16 December 2004
- journal article
- Published by Springer Nature in Journal of Perinatology
- Vol. 25 (3) , 156-161
Abstract
OBJECTIVE: STUDY DESIGN: RESULTS: CONCLUSION:Keywords
This publication has 21 references indexed in Scilit:
- Application of the Polymerase Chain Reaction to the Diagnosis and Management of Neonatal Herpes Simplex Virus DiseaseThe Journal of Infectious Diseases, 1996
- Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a Phase I/II trialThe Pediatric Infectious Disease Journal, 1996
- Dosing considerations for oral acyclovir following neonatal herpes diseaseActa Paediatrica, 1994
- Recurrence and Resistance Patterns of Herpes Simplex Virus following Cessation of >=6 Years of Chronic Suppression with AcyclovirThe Journal of Infectious Diseases, 1994
- Safety of acyclovir: A summary of the first 10 years experienceJournal of Medical Virology, 1993
- A Follow‐up Study of Children with Neonatal Herpes Simplex Virus Infections with Particular Regard to Late Nervous DisturbancesActa Paediatrica, 1991
- Acyclovir concentrations in serum and cerebrospinal fluid at steady stateJournal of Antimicrobial Chemotherapy, 1989
- Neonatal herpes simplex virus infectionThe Pediatric Infectious Disease Journal, 1989
- DIFFERENCE BETWEEN HERPES SIMPLEX VIRUS TYPE I AND TYPE 2 NEONATAL ENCEPHALITIS IN NEUROLOGICAL OUTCOMEThe Lancet, 1988
- Similar hematologic changes in children receiving trimethoprim-sulfamethoxazole or amoxicillin for otitis mediaThe Journal of Pediatrics, 1985